NIT-OCCLUD PDA Phase II Sentinel Trial

Completed · Not applicable

Conditions studied: Ductus Arteriosus, Patent

In brief

The purpose of this study is to evaluate the safety and efficacy of the Nit-Occlud -PDA Occlusion System for transcatheter closure of PDA with minimum angiographic diameter less than 4 mm, and to compare one year safety and efficacy outcomes with recommended OPCs.

Key facts

Study ID
NCT00828334
Run by
PFM Medical, Inc
People needed
357
Starts
2002-11-01
Expected to finish
2007-10-01
Last updated by the study team
2018-03-23

Who can join

Age: 1 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.